Ativa’s technology can detect pathogens (COVID-19) days before the viral load is even detectable by PCR and before symptoms appear. The workstation is point-of-care, enabling rapid quarantine. The underlying technology was designed for bio-warfare, funded by the Dept. of Defense and co-developed with Honeywell and 3M.
Ativa’s 5-minute CBC with machine-learning provides the earliest possible detection of a new pathogen and enables rapid containment.
Ativa’s technology can detect pathogens (COVID-19) days before the viral load is even detectable by PCR and before symptoms appear. The workstation is point-of-care, enabling rapid quarantine. The underlying technology was designed for bio-warfare, funded by the Dept. of Defense and co-developed with Honeywell and 3M.
We provide the most critical test results in 5 minutes
Ativa will provide Emergency Care clinicians the most needed test results within 5-minutes at the point of care. Our Machine learning will provide deeper insights from A.I. driven algorithms alerting the clinician to serious underlying diseases.
We provide the most critical test results in 5 minutes
Ativa will provide Emergency Care clinicians the most needed test results within 5-minutes at the point of care. Our Machine learning will provide deeper insights from A.I. driven algorithms alerting the clinician to serious underlying diseases.
More Time Healing, Less Time Waiting
Primary care clinicians and their patients can have convenient, rapid and high-quality tests done immediately at the clinic. No more waiting for next-day send-out results, just a drop of blood or urine to diagnose or monitor common disorders.
More Time Healing, Less Time Waiting
Primary care clinicians and their patients can have convenient, rapid and high-quality tests done immediately at the clinic. No more waiting for next-day send-out results, just a drop of blood or urine to diagnose or monitor common disorders.
Impacting global healthcare to improve lives everywhere
Ativa will provide the most commonly needed tests in the world, coupled with machine-learned software as the new biomarkers, detecting problem diseases for a very low cost for all people
Impacting global healthcare to improve lives everywhere
Ativa will provide the most commonly used tests in the world, coupled with machine-learning A.I., to detect underlying diseases at a very low cost for all people globally
We Are Experienced Agents of Disruption.
Ativa’s team has successfully commercialized and implemented A.I. based medical technologies before. We’ve launched companies on NASDAQ, and we are a team of world class technologists, scientists, partners generating valuable and innovative solutions.
We Are Experienced Agents of Disruption.
Ativa’s team has successfully commercialized and implemented A.I. based medical technologies before. We’ve launched companies on NASDAQ, and we are a team of world class technologists, scientists, partners generating valuable and innovative solutions.